Ligand plus enhancer for improved stability and enhanced immune activation.
Shipping: Available products typically ship within 24/48h, via priority shipping.
Do you need support? Contact Customer Service or Technical Support.
Online Account
Access or Create Your Account

Figure 3: Phenotypic characterization of unstimulated (left panels) and CD40-stimulated (right panels) pre-B ALL cells from a patient cultured on human bone marrow stroma layer for 48 hours. Histograms represent the fluorescence distribution by monoclonal antibodies to CD80 and CD86 as analyzed by flow cytometry for a representative case. Figure kindly provided by Dr. Elisabetta Todisco, Molecular Immunohematology Laboratory, Centro Ricerca M.Tettamanti, University of Milano Bicocca, Monza.

Figure 1: Stimulation of B-cell precursor (BCP) acute lymphoblastic leukemia by CD40L, Soluble (human) (rec.). Phenotypic characterization of unstimulated (left panels) and Cd40-stimulated (right panels) pre B ALL cells from a patient cultured on human bone marrow stroma layer for 48 hours. Histograms represent the fluorescence distribution by MAb to CD80 as analyzed by flow cytometry for a representative case. Figure kindly provided by Dr. Elisabetta Todisco, Molecular Immunohematology Laboratory, Centro Ricerca M.Tettamanti, University of Milano Bicocca, Monza.


Product Details
Alternative Name |
CD154, TNFSF 5 |
---|---|
Application |
FUNC |
Application Notes |
Can be used to activate human B cells and dendritic cells. Stimulates growth of human B cells. For stimulation of mouse cells via CD40 use MAb to CD40 (mouse) (FGK45) (Prod. No. ALX-805-046). |
Concentration |
CD40L: 0.1mg/ml after reconstitutionEnhancer: 1mg/ml |
Contents |
10µg of CD40L, Soluble (human) (recombinant) (Prod. No. ALX-522-015) and 2×50µg of Enhancer for Ligands (Prod. No. ALX-804-034), which increases the biological activity of rhsCD40L at least 1’000-fold. |
Formulation |
CD40L: Lyophilized. Contains PBS. |
Purity |
≥95% (SDS-PAGE). |
Reconstitution |
Reconstitute CD40L with 100µl sterile water. Further dilutions should be made with medium containing 5% fetal calf serum or carrier protein. |
Source |
Produced in E. coli. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to a linker peptide (6 aa) and a FLAG®-tag. |
Specificity |
CD40L binds to human CD40. |
Technical Info / Product Notes |
CD40L (Prod. No. ALX-522-015) and Enhancer for Ligands (Prod. No. ALX-804-034) should be incubated together for 30 min. at room temperature prior to cell application. Effects are typically best seen with 0.5-10µg/ml of CD40L together with 1-2µg/ml of enhancer. This may vary by cell type and experimental conditions. FLAG is a registered trademark of Sigma-Aldrich Co. |
UniProt ID |
P29965 |
Handling & Storage
Use/Stability |
Stable for at least 6 months after receipt when stored at -20°C. |
---|---|
Handling |
Avoid freeze/thaw cycles. After reconstitution, prepare aliquots and store at -20°C. |
Long Term Storage |
-20°C |
Shipping |
Blue Ice |
Regulatory Status |
RUO – Research Use Only |
---|
- Phospholipase C-γ as a Potential Therapeutic Target for Graves’ Orbitopathy: Roh, T. H., Chae, M. K., et al.; Endocrinol. Metab. (Seoul) 38, 739 (2023), Abstract
- Interferon inducible X-linked gene CXorf21 may contribute to sexual dimorphism in Systemic Lupus Erythematosus: C.A. Odhams, et al.; Sci. Rep. 10, 2164 (2019), Abstract — Full Text
- Artesunate shows potent anti-tumor activity in B-cell lymphoma: T. K. Vatsveen, et al.; J. Hematol. Oncol. 11, 23 (2018), Abstract — Full Text
- Maturation-dependent expression of AIM2 in human B-cells: A. Svensson, et al.; Plos One 12, e0183268 (2017), Application(s): Human B-cells derived from adult and cord blood, Abstract — Full Text
- BMP-7 induces apoptosis in human germinal center B cells and is influenced by TGF-β receptor type I ALK5: L.K. Bollum, et al.; PLoS One 12, e0177188 (2017), Abstract — Full Text
- Characterization of ASKP1240, a Fully Human Antibody Targeting Human CD40 With Potent Immunosuppressive Effects: K. Okimura, et al.; Am. J. Transplant 14, 1290 (2014), Application(s): Cell Culture, Abstract — Full Text
- Novel selective inhibitors of nuclear export CRM1 antagonists for therapy in mantle cell lymphoma: K. Zhang, et al.; Exp. Hematol. 41, 67 (2013), Application(s): Cell Culture, Abstract
- Enhanced activation of human dendritic cells by inducible CD40 and Toll-like receptor-4 ligation: N. Lapteva, et al.; Cancer Res. 67, 10528 (2007), Abstract
- TNF receptor-associated factor 6 is an essential mediator of CD40-activated proinflammatory pathways in monocytes and macrophages: L. Mukundan, et al.; J. Immunol. 174, 1018 (2005), Abstract — Full Text
- CD40 induces human multiple myeloma cell migration via phosphatidylinositol 3-kinase/AKT/NF-kappa B signaling: Y.T. Tai, et al.; Blood 101, 2762 (2003), Abstract
- IL-4 down-regulates anaphylatoxin receptors in monocytes and dendritic cells and impairs anaphylatoxin-induced migration in vivo: A. Soruri, et al.; J. Immunol. 170, 3306 (2003), Abstract — Full Text
- Induction of antigen-specific CTL by recombinant HIV trans-activating fusion protein-pulsed human monocyte-derived dendritic cells: Y. Tanaka, et al.; J. Immunol. 170, 1291 (2003), Abstract — Full Text
- Platelet-Activating Factor Mediates CD40-Dependent Angiogenesis and Endothelial-Smooth Muscle Cell Interaction: S. Russo, et al.; J. Immunol. 171, 5489 (2003), Abstract
- The novel IgD binding protein from Moraxella catarrhalis induces human B lymphocyte activation and Ig secretion in the presence of Th2 cytokines: A. Gjorloff Wingren, et al.; J. Immunol. 168, 5582 (2002), Abstract — Full Text
- Synergy between CD40 ligation and IL-4 on fibroblast proliferation involves IL-4 receptor signaling: S.P. Atamas, et al.; J. Immunol. 168, 1139 (2002), Abstract — Full Text
- Brain dendritic cells and macrophages/microglia in central nervous system inflammation: H.G. Fischer & G. Reichmann; J. Immunol. 166, 2717 (2001), Abstract — Full Text
- CD40 induces apoptosis in carcinoma cells through activation of cytotoxic ligands of the tumor necrosis factor superfamily: A.G. Eliopoulos, et al.; Mol. Cell. Biol. 20, 5503 (2000), Abstract
- CD45 inhibits CD40L-induced microglial activation via negative regulation of the Src/p44/42 MAPK pathway: J. Tan, et al.; J. Biol. Chem. 275, 37224 (2000), Abstract — Full Text
- Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity: P. Schneider, et al.; J. Exp. Med. 187, 1205 (1998), Abstract — Full Text
Related Products

Alternative Name | CD154, TNFSF 5, gp39 |
---|---|
Purity | ≥95% (SDS-PAGE) |
Source | Produced in E. coli. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to a linker peptide (6 aa) and a FLAG®-tag. |
MEGACD40L® Protein (soluble) (human), (recombinant)
ALX-522-110
High activity, high purity CD40L protein for co-stimulatory activation of an immune response

Alternative Name | CD40L:ACRP30headless, CD154:ACRP30headless, TNFSF 5:ACRP30headless, gp39:ACRP30headless |
---|---|
Purity | ≥90% (SDS-PAGE) |
Source | Produced in CHO cells. The extracellular domain of human CD40L (CD154) (aa 116-261) is fused at the N-terminus to mouse ACRP30headless (aa 18-111) and a FLAG®-tag. |

Alternative Name | TNFRSF 5 |
---|---|
Application | ELISA, Flow Cytometry, FUNC, WB |
Host | Rat |
Isotype | IgG2a |
Species Reactivity | Mouse |
Enhancer for Ligands
ALX-804-034
Enhances biological activity of TRAIL, soluble (human) (recombinant) and FasL, soluble (human) (recombinant).

Datasheet, Manuals, SDS & CofA
Manuals And Inserts
Certificate of Analysis
Please enter the lot number as featured on the product label
SDS
Enzo Life Science provides GHS Compliant SDS
If your language is not available please fill out the SDS request form